One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Exoskeleton Market

[ 英語タイトル ] Exoskeleton Market - Growth, Trends, and Forecasts (2020 - 2025)

Product Code : MDHC0082708
Survey : Mordor Intelligence
Publish On : November, 2020
Category : Healthcare and Pharmaceuticals
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Cyberdyne Inc.
- Ekso Bionics Holdings
- Rewalk Robotics
- Bionik Laboratories Corp.
- Parker-Hannifin Corp.
- Bioservo Technologies AB
- Gogoa Mobility Robots
- Rehab-Robotics Company Limited
- Bioness Inc.
- B-Temia Inc.

[Report Description]

The exoskeleton market was found witnessing a CAGR of 42.87%. The major factors propelling the market growth are the rising prevalence of stroke, increasing adoption of the exoskeleton, and growing geriatric population at a global level are some of the key factors anticipated to influence the market growth over the forecast period. Moreover, the growing usage of the exoskeleton healthcare industry is anticipated to drive the global market over the forecast period.

In addition, with the increasing number of disabled people, there has been an increase in the demand for robotic rehabilitation around the globe. The role of technology in healthcare has become evident with the enhanced rate of survival from medical disorders such as stroke. Robotic rehabilitation and assistive technologies, therefore, promise to ease the stress on the physiotherapy staff and control expenses while refining patients’ quality of life. On the other hand, the cost of the exoskeleton is generally found to be high and is not affordable by most people in need. However, there are many efforts taking place in order to reduce these prices by developing cheaper components so that the technology become more accessible for people.

Key Market Trends

Mobile Segment is Expected to hold the Highest Market Share in the Product Type

Mobile Exoskeleton is the products/devices that are found supporting the powered hip and knee motion to enable individuals with spinal cord injuries to stand and walk. Exoskeletons can cover the entire body or even a specific body segment such as the ankle or the hip. Therefore the mobile exoskeleton is anticipated to witness significant growth as they can be worn outside or in a person’s home. They are also found supporting the powered hip and knee motion to enable individuals with spinal cord injuries to stand and walk. Hence the system can be controlled by a physical therapist or can be controlled by the user.

North America Dominates the Market and is Expected to do the Same in the Forecast Period

North America is the dominant in the exoskeleton market in the world, with the United States controlling the major share. The key factors responsible for the large share includes the growing geriatric population, high purchasing power of patients, and presence of public and private organizations offering grants & funds for the development of technologically advanced products.

Furthermore, increasing prevalence of spinal cord injury (SCI) is one of the leading factors expected to increase the adoption of exoskeleton in the United States. Thus, presence huge cases of spinal cord injury (SCI) and stroke associated disability factor is expected to show growth in the coming years. Furthermore, increasing number of FDA approvals on medical exoskeletons and rising awareness regarding technologically advanced systems are likely to increase the demand for exoskeletons in the region.

Competitive Landscape

Some of the key players in the market studied are Cyberdyne, Ekso Bionics Holdings, Rewalk Robotics, Bionik Laboratories and among others. Therefore the increasing investments by these players in the development of new and innovative products and FDA approvals on their products are supporting the market growth.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Demand From Healthcare Sector for Robotic Rehabilitation
4.2.2 Advancement in Robotic Technologies
4.2.3 Huge Investment for the Development of the Exoskeleton Technology
4.3 Market Restraints
4.3.1 Risks Involved With Using Exoskeletons Due to Vague Safety Guidelines
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Treatment Type
5.1.1 Rehabilitation
5.1.2 Augmentation
5.2 By Body Part Type
5.2.1 Upper Body
5.2.2 Lower Body
5.3 By Product Type
5.3.1 Stationary
5.3.2 Mobile
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle-East and Africa GCC South Africa Rest of Middle East and Africa
5.4.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Cyberdyne Inc.
6.1.2 Ekso Bionics Holdings
6.1.3 Rewalk Robotics
6.1.4 Bionik Laboratories Corp.
6.1.5 Parker-Hannifin Corp.
6.1.6 Bioservo Technologies AB
6.1.7 Gogoa Mobility Robots
6.1.8 Rehab-Robotics Company Limited
6.1.9 Bioness Inc.
6.1.10 B-Temia Inc.




Recommended reports